GlassScriptPhysician profile
Eericca M Bickley
NPI 1023250529
$8,377.44
in general payments reported to CMS, 2019-2025
31 companies · $456 in 2025
The $456 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $202 · 2021: $6,369 · 2022: $466 · 2023: $479 · 2024: $95.50 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,030.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,011.94 | 2021 | |
| Abbvie INC. | $566.15 | 2019-2023 | Lo Loestrin Fe, Liletta |
| Hologic Sales and Service, LLC | $499.24 | 2019-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Acessa Provu System, Omni Hysteroscope |
| Sumitomo Pharma America, INC. | $147.37 | 2023-2024 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $132.94 | 2019-2024 | |
| Vertex Pharmaceuticals Incorporated | $120.36 | 2025 | |
| Daiichi Sankyo INC. | $97.67 | 2019-2022 | |
| Organon LLC | $84.41 | 2022-2023 | Nexplanon |
| Gynesonics, INC. | $73.30 | 2022 | |
| Mayne Pharma Commercial LLC | $70.18 | 2022-2023 | |
| Myovant Sciences INC. | $63.75 | 2022 | |
| Aspira Women'S Health INC | $59.02 | 2022-2023 | Ova1 |
| Therapeuticsmd, INC. | $53.82 | 2020-2021 | |
| Biogen, INC. | $48.75 | 2024-2025 | Zurzuvae |
| Smith+Nephew, INC. | $36.16 | 2024-2025 | Pico 7, Pico 14 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $35.18 | 2024-2025 | |
| Boston Scientific Corporation | $31.96 | 2019 | |
| Astellas Pharma US INC | $28.43 | 2025 | Veozah |
| Dexcom, INC. | $24.76 | 2023 | Dexcom G6 Transmitter |
| Millicent US INC | $20.30 | 2019 | |
| Exeltis, USA INC. | $19.28 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.38 | 2022 | |
| Minerva Surgical, INC | $18.00 | 2019 | |
| Cook Medical LLC | $16.45 | 2023 | Guardia |
| Merck Sharp & Dohme LLC | $16.41 | 2019 | |
| Evofem Biosciences, INC. | $16.16 | 2021 | |
| Optumhealth Care Solutions, LLC | $14.60 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Amag Pharmaceuticals, INC. | $14.53 | 2019 | |
| Coopersurgical, INC. | $13.74 | 2022 | |
| Medtronic, INC. | $13.60 | 2022 | |
| Meditrina | $10.60 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eericca Bickley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.